InvestorsHub Logo

b9molecule

12/29/15 3:23 PM

#31300 RE: unclecash #31299

its not a threat, its a fact.

As of Oct. 31, 2015, there were 78,448,620 shares of the registrant’s Common Stock outstanding.
As of May 5, 2015, there were 74,503,120 shares of the registrant’s Common Stock outstanding.
As of Feb. 13, 2015, there were 73,363,120 shares of the registrant’s Common Stock outstanding.
As of Oct. 31, 2014, there were 69,088,120 shares of the registrant’s Common Stock outstanding.

So, in a year's time roughly 9.4M new shares issued. Thats approx. 14% dilution y/y

its all in the filings
http://www.sec.gov/cgi-bin/browse-edgar?company=implant+sciences&owner=exclude&action=getcompany

Buzzlityr

12/29/15 4:45 PM

#31302 RE: unclecash #31299

Uncle-- you are not quite getting it: IMSC is a poisoned stock due to daily-ongoing dilution. That is why a few shorts play the stock-- they know for a FACT, that DM will provide cover shares-every single day.

That un-dynamic has killed interest in the stock. IMO, the company PRs have lost any power to lift the SP and until that changes, the SP will spiral downward. One might say: why is mgt. letting this happen? One possible answer: BM/DJ and or both receive 1% of outstanding share count as an optional conversion at the price set when/on the day they together or singly bring at least 15M$ in NEW financing to ISC. More shares diluting = higher float share count and lower SP= a delightful option award.

tedpeele

12/29/15 7:31 PM

#31305 RE: unclecash #31299

Yes, but there is no question they sold a lot in 2014 and through Sep 2015. Little reason to think that has changed, although it is possible, as the lower the price goes the less incentive they have to sell.